Tuvalu vs Western Pacific (WHO region): Previously treated cases tested for RR-/MDR-TB
Tuvalu
100.0%
in 2021
Western Pacific (WHO region)
86.0%
in 2024
Tuvalu rank
1st
Western Pacific (WHO region) rank
3rd
Previously treated cases tested for RR-/MDR-TB over time
- Tuvalu
- Western Pacific (WHO region)
How they compare
Tuvalu currently reports 100.0% against 86.0% in Western Pacific (WHO region), a difference of 14.0%.
That makes Tuvalu's figure about 1.2 times Western Pacific (WHO region)'s.
The two have swapped places 1 time across 6 shared years of data; in 2014 it was Western Pacific (WHO region) ahead.
Tuvalu ranks 1st and Western Pacific (WHO region) ranks 3rd of 180 countries.
Across the 2 decades both report, Tuvalu averaged higher in 1 and Western Pacific (WHO region) in 1.
Head to head by decade
| Decade | Tuvalu | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 36.8% | 81.2% | 44.5% | Western Pacific (WHO region) |
| 2020s | 100.0% | 91.5% | 8.5% | Tuvalu |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Tuvalu or Western Pacific (WHO region)?
- Tuvalu, at 100.0% against 86.0% in Western Pacific (WHO region) as of 2021.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Tuvalu and Western Pacific (WHO region)?
- 14.0%, with Tuvalu ahead.
- How many years of comparable data are there for Tuvalu and Western Pacific (WHO region)?
- 6 years are reported by both, from 2014 to 2021.
- How do Tuvalu and Western Pacific (WHO region) rank globally for previously treated cases tested for rr-/mdr-tb?
- Tuvalu ranks 1st and Western Pacific (WHO region) ranks 3rd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.